Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[⁶⁸Ga]Ga-FAP-2286 PET/CT in Primary Breast Cancer
NCT07523607Phase 2Not yet recruiting
- Sponsor
- University Hospital Odense
- Start
- Jun 2026
- Primary completion
- Jan 2028
- Modality
- Small Molecules, Peptide-Drug Conjugates
01
Overview
A Phase 2 trial of 68Ga-FAP-2286 in breast cancer, sponsored by University Hospital Odense. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
68Ga-FAP-2286
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT07523607.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07523607.